| A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer G Bertolini, V Cancila, M Milione, GL Russo, O Fortunato, N Zaffaroni, ... Molecular Therapy 29 (10), 2963-2978, 2021 | 15 | 2021 |
| A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements S Martin, S Scorzoni, S Cordone, A Mazzagatti, GV Beznoussenko, ... Science 385 (6712), eadj7446, 2024 | 2 | 2024 |
| A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia L Menin, J Weber, S Villa, E Martini, E Maspero, CA Niño, V Cancila, ... Cell reports 42 (8), 2023 | 1 | 2023 |
| A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer C Chiodoni, S Sangaletti, M Lecchi, CM Ciniselli, V Cancila, I Tripodi, ... ESMO open 8 (4), 101590, 2023 | 1 | 2023 |
| Abstract A24: Bone marrow hematopoietic adaptation as a sensor of early, pre-invasive, epithelial malignancy C Chiodoni, AM Tomirotti, TA Renzi, M Dugo, V Cancila, C Tripodo, ... Cancer Research 78 (10_Supplement), A24-A24, 2018 | | 2018 |
| Anaplastic Large T Cell Lymphoma (ALCL) is characterized by high expression of P-Selectin Glycoprotein Ligand 1 (PSGL-1) that positively correlates with CD30 expression and TCR … W Arancio, A Gulino, V Cancila, P Piccaluga, P Macor, A Di Napoli, ... | | 2016 |
| Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 403 | 2019 |
| ATR expands embryonic stem cell fate potential in response to replication stress S Atashpaz, S Samadi Shams, JM Gonzalez, E Sebestyen, ... Elife 9, e54756, 2020 | 46 | 2020 |
| B cell receptor silencing reveals the origin of high-grade B cell lymphomas with MYC and BCL2 rearrangements P Sindaco, S Lonardi, G Varano, I Pietrini, G Morello, P Balzarini, ... bioRxiv, 2024.07. 13.603066, 2024 | | 2024 |
| BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS B eatrice Belmonte, A Mangogna, D Bonazza, C Agostinis, A Gulino, ... PATHOLOGICA 110, 171-171, 2018 | | 2018 |
| Bone marrow hematopoietic adaptation as a sensor of early, pre-invasive, epithelial malignancy. C Chiodoni, AM Tomirotti, TA Renzi, M Dugo, V Cancila, C Tripodo, ... CANCER RESEARCH 78 (10), 42-43, 2018 | | 2018 |
| Breast cancer organoids model patient-specific response to drug treatment E Campaner, A Zannini, M Santorsola, D Bonazza, C Bottin, V Cancila, ... Cancers 12 (12), 3869, 2020 | 56 | 2020 |
| Castration-induced downregulation of SPARC in stromal cells drives neuroendocrine differentiation of prostate cancer C Enriquez, V Cancila, R Ferri, R Sulsenti, I Fischetti, M Milani, P Ostano, ... Cancer Research 81 (16), 4257-4274, 2021 | 15 | 2021 |
| Circulating mir-320 promotes immunosuppressive macrophages M2 phenotype associated with lung cancer progression O Fortunato, C Borzi, M Milione, G Centonze, D Conte, M Boeri, M Moro, ... Cancer Research 78 (13_Supplement), 4981-4981, 2018 | | 2018 |
| Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk O Fortunato, C Borzi, M Milione, G Centonze, D Conte, M Boeri, C Verri, ... International journal of cancer 144 (11), 2746-2761, 2019 | 68 | 2019 |
| Cisplatin-induced activation of SDF-1/CXCR4 axis sustains lung cancer metastasis by promoting co-recruitment of metastasis initiating cells and inflammatory monocytes G Bertolini, V Cancila, O Fortunato, GL Russo, M Tortoreto, G Centonze, ... Cancer Research 80 (16_Supplement), 1106-1106, 2020 | | 2020 |
| CK2β-regulated signaling controls B cell differentiation and function L Quotti Tubi, E Mandato, S Canovas Nunes, A Arjomand, F Zaffino, ... Frontiers in Immunology 13, 959138, 2023 | 2 | 2023 |
| Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response I Fischetti, L Botti, R Sulsenti, V Cancila, C Enriquez, R Ferri, M Bregni, ... Epigenomics, 2024 | | 2024 |
| Combined therapy targeting AR and EZH2 restrains the growth of castration resistant prostate cancer by enhancing antitumor T cell response I Fischetti, B Laura, R Sulsenti, V Cancila, C Enriquez, R Ferri, M Bregni, ... Cancer Research 84 (6_Supplement), 2639-2639, 2024 | | 2024 |
| Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion GP de Freitas Nader, S Agüera-Gonzalez, F Routet, M Gratia, M Maurin, ... Cell 184 (20), 5230-5246. e22, 2021 | 140 | 2021 |
